Komori
COSMOS Pharmaceutical (3349) · InitiativeRestated

Transition to a Company with an Audit and Supervisory Committee

First written in FY2016. 8 of 9 entries say "Restated". Latest entry: FY2026.

9entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20262016: 12017: 120172018: 120182019: 120192020: 020202021: 120212022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Transition to a Company with an Audit and Supervisory CommitteeA theme 782 companies write about · 0 as a headwind · 791 as a tailwind

84 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 791 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Based on a resolution adopted at the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an audit and supervisory committee on the same date.」

    The company continues to maintain a structure for strengthening the Board of Directors’ audit and supervisory functions through its audit and supervisory committee.
  2. FY2024RestatedAnnual report

    「Based on a resolution adopted at the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an audit and supervisory committee on the same date.」

    The company continues to maintain a structure for strengthening audit and supervisory functions through its audit and supervisory committee.
  3. FY2023RestatedAnnual report

    「Based on a resolution adopted at the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an audit and supervisory committee on the same date.」

    The company continues to maintain a structure for strengthening audit and supervisory functions through its audit and supervisory committee.
  4. FY2022RestatedAnnual report

    「Based on a resolution adopted at the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an audit and supervisory committee on the same date.」

    The company continues to describe its company-with-an-audit-and-supervisory-committee structure and the reasons for strengthening its audit and supervisory functions.
  5. FY2021RestatedAnnual report

    「Based on a resolution adopted at the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an audit and supervisory committee on the same date.」

    The company continues to describe its company-with-an-audit-and-supervisory-committee structure and the reasons for strengthening its audit and supervisory functions.
  6. FY2019RestatedAnnual report

    「Based on a resolution adopted at the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an audit and supervisory committee on the same date.」

    The company continues to maintain a structure that strengthens the Board of Directors’ audit and supervisory functions and corporate governance by granting voting rights to directors who serve as Audit and Supervisory Committee members.
  7. FY2018RestatedAnnual report

    「Pursuant to a resolution of the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an Audit and Supervisory Committee on the same date.」

    The company continues to describe its company-with-an-audit-and-supervisory-committee structure and the reasons for strengthening its audit and supervisory functions.
  8. FY2017RestatedAnnual report

    「Pursuant to a resolution of the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an Audit and Supervisory Committee on the same date.」

    The company continues to describe its company-with-an-audit-and-supervisory-committee structure and the reasons for strengthening its audit and supervisory functions.
  9. FY2016First statedAnnual report

    「Pursuant to a resolution of the 33rd Annual General Meeting of Shareholders held on 21 August 2015, the company changed from a company with a board of corporate auditors to a company with an Audit and Supervisory Committee on the same date.」

    The company transitioned to a structure intended to strengthen the Board of Directors’ audit and supervisory functions and corporate governance by giving directors who serve on the Audit and Supervisory Committee voting rights.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Transition to a Company with an Audit and Supervisory Committee | COSMOS Pharmaceutical Corporation (3349) | Komori